E-Cigarette Use Among persons With Diagnosed HIV in the U.S.

Details

• Alternative Title:
  AJPM Focus
• Personal Author:
  Thorne, Stacy L. ; Caraballo, Ralph S. ; Tie, Yunfeng ; Harris, Norma S. ; Shouse, R. Luke ; Brooks, John T.
• Description:
  Introduction:
  
  E-cigarettes emerged in the U.S. market in the late 2000s. In 2017, E-cigarette use among U.S. adults was 2.8%, with higher use among some population groups. Limited studies have assessed E-cigarette use among persons with diagnosed HIV. The purpose of this study is to describe the national prevalence estimates of E-cigarette use among persons with diagnosed HIV by selected sociodemographic, behavioral, and clinical characteristics.
  
  Methods:
  
  Data were collected between June 2018 and May 2019 as part of the Medical Monitoring Project, an annual cross-sectional survey that produces nationally representative estimates of behavioral and clinical characteristics of persons with diagnosed HIV in the U.S. Statistically significant differences (p<0.05) were determined using chi-square tests. Data were analyzed in 2021.
  
  Results:
  
  Among persons with diagnosed HIV, 5.9% reported currently using E-cigarettes, 27.1% had ever used them but were not using them currently, and 72.9% had never used them. Current use of E-cigarettes was highest among persons with diagnosed HIV who currently smoke conventional cigarettes (11.1%), those with major depression (10.8%), those aged 25–34 years (10.5%), those who reported injectable and noninjectable drug use in the past 12 months (9.7%), those diagnosed <5 years ago (9.5%), those who self-reported sexual orientation as other (9.2%), and non-Hispanic White people (8.4%).
  
  Conclusions:
  
  Overall, findings suggest that a greater proportion of persons with diagnosed HIV used E-cigarettes than the overall U.S. adult population and that higher rates were observed among certain subgroups, including those who currently smoke cigarettes. E-cigarette use among persons with diagnosed HIV warrants continued attention because of its potential impact on HIV-related morbidity and mortality.
  
  
• Source:
  AJPM Focus. 2(1)
• Pubmed ID:
  37206980
• Pubmed Central ID:
  PMC10193385
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Volume:
  2
• Issue:
  1
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:661e07cb2934d392b8d4ba532b57c3ba0ac75d68ac78f123fa0b7f472ec9806381cab1e2bfe7d79436185e0039b937afeb175b396808885d40b387c1954eb63a
• Download URL:
  https://stacks.cdc.gov/view/cdc/128756/cdc_128756_DS1.pdf
• File Type:
  [PDF - 405.96 KB ]